halothane has been researched along with methylprednisolone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cain, PA; Ellis, FR | 1 |
| Bake, I; Buttazzoni, E; Csongrady, A; Pfänder, C; Schneider, M; Tarmann, H | 1 |
| King, TD; Lawson, NW; Mills, NL; Ochsner, JL; Williams, LC | 1 |
| Shealy, CN | 1 |
| Cardinaud, JP; Favier, JC; Gbikpi-Benissan, G; Gruson, D; Hilbert, G; Portel, L | 1 |
8 other study(ies) available for halothane and methylprednisolone
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Anaesthesia for patients susceptible to malignant hyperpyrexia. A study of pancuronium and methylprednisolone.
Topics: Anesthesia; Contracture; Dose-Response Relationship, Drug; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Methylprednisolone; Muscle Contraction; Pancuronium | 1977 |
[A further case of malignant hyperpyrexia and its treatment with lidocaine, methylprednisolone and verapamil (iproveratril) (author's transl)].
Topics: Acidosis; Adult; Calcium; Cryotherapy; Glucose; Halothane; Humans; Insulin; Lidocaine; Male; Malignant Hyperthermia; Methylprednisolone; Muscle Relaxants, Central; Oxygen; Succinylcholine; Verapamil | 1976 |
Technic of deep hypothermia and circulatory arrest in the neonate and infant.
Topics: Blood Volume; Body Temperature Regulation; Extracorporeal Circulation; Female; Halothane; Heart Arrest, Induced; Heart Defects, Congenital; Humans; Hypothermia, Induced; Infant; Infant, Newborn; Male; Methylprednisolone; Preanesthetic Medication | 1976 |
Dangers of spinal injections without proper diagnosis.
Topics: Anesthesia, Inhalation; Cerebrospinal Fluid Proteins; Chloramphenicol; Diagnosis, Differential; Diatrizoate; Halothane; Humans; Injections, Spinal; Intervertebral Disc; Laminectomy; Male; Methylprednisolone; Middle Aged; Myelography; Neurosurgery; Spinal Cord Diseases; Sulfisoxazole | 1966 |
Malignant hyperthermia and neuroleptic malignant syndrome in a patient during treatment for acute asthma.
Topics: Acute Disease; Adjuvants, Anesthesia; Adult; Anesthetics, Inhalation; Asthma; Bronchodilator Agents; Calcium Channel Blockers; Dantrolene; Droperidol; Glucocorticoids; Halothane; Humans; Intubation, Intratracheal; Magnesium Sulfate; Male; Malignant Hyperthermia; Methylprednisolone; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Neuromuscular Blocking Agents; Respiration, Artificial; Rhabdomyolysis | 1999 |